Taro Pharmaceutical Industries Ltd.Yakum, Israel (Pink Sheets: TAROF)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Taro Income Statement

All amounts in millions of except per share amounts.
View: Annual | Quarterly
Dec 05 Dec 04 Dec 03
Revenue 297.7 284.1 315.5
Cost of Goods Sold 128.7 119.4 102.4
Gross Profit 169.0 164.7 213.0
Gross Profit Margin 56.8% 58.0% 67.5%
SG&A Expense 128.6 145.6 123.9
Depreciation & Amortization 25.3 19.6 14.4
Operating Income 15.2 (0.5) 74.7
Operating Margin 5.1% -- 23.7%
Nonoperating Income (1.6) (6.4) 1.0
Nonoperating Expenses 6.3 -- 2.7
Income Before Taxes 7.3 (6.9) 73.0
Income Taxes 1.6 (17.0) 11.5
Net Income After Taxes 5.7 10.1 61.5

Continuing Operations 5.7 11.1 61.2
Discontinued Operations -- -- --
Total Operations 5.7 11.1 61.2
Total Net Income 5.7 11.1 61.2
Net Profit Margin 1.9% 3.9% 19.4%

Diluted EPS from Total Net Income ($) 0.19 0.37 2.06
Dividends per Share -- -- --
Edgar Online logo
This data is provided as per license from EDGAR Online